Xencor to Host Second Quarter 2023 Financial Results Webcast and Conference Call on August 3, 2023Business Wire • 07/27/23
Xencor Presents Clinical Results from Phase 1a Study of XmAb®564 at the EULAR 2023 CongressBusiness Wire • 05/30/23
Xencor to Host First Quarter 2023 Financial Results Webcast and Conference Call on May 8, 2023Business Wire • 05/01/23
Xencor Highlights CD28 Bispecific Antibody Platform at AACR Annual Meeting 2023Business Wire • 04/17/23
Xencor to Present Preclinical Data from Novel XmAb® CD28 Bispecific Antibody Programs at the American Association for Cancer Research Annual Meeting 2023Business Wire • 03/14/23
Strength Seen in Xencor (XNCR): Can Its 5.3% Jump Turn into More Strength?Zacks Investment Research • 03/14/23
Xencor to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023Business Wire • 02/16/23